These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8097116)

  • 1. Should DSM-III-R GAD criteria be used for studies of anxiolytics?
    Mattes JA; Konig PH
    Biol Psychiatry; 1993 Feb; 33(4):302-3. PubMed ID: 8097116
    [No Abstract]   [Full Text] [Related]  

  • 2. Choice of rating form for evaluating anxiolytics.
    Wang RI; Kochar C
    Psychopharmacol Bull; 1989; 25(2):291-5. PubMed ID: 2574898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
    Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
    Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of RDC, DSM-III, DSM-III-R diagnostic criteria for generalized anxiety disorder.
    Wolk SI; Horwath E; Goldstein RB; Wickramaratne P; Weissman MM
    Anxiety; 1996; 2(2):71-9. PubMed ID: 9160604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of anxiety in outpatient trials: detection of bias in patient and doctor ratings.
    Fisher S
    Psychopharmacol Bull; 1976 Apr; 12(2):17-8. PubMed ID: 3818
    [No Abstract]   [Full Text] [Related]  

  • 8. Bromazepam in generalized anxiety. Randomized, multi-practice comparisons with both chlorprothixene and placebo.
    Kragh-Sørensen P; Holm P; Fynboe C; Schaumburg E; Andersen B; Bech P; Pichard J
    Psychopharmacology (Berl); 1990; 100(3):383-6. PubMed ID: 1969172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical investigations of some anxiolytics drugs.
    Welbel SL
    Agressologie; 1981 Oct; 22(C):39-40. PubMed ID: 6119919
    [No Abstract]   [Full Text] [Related]  

  • 11. A preliminary evaluation of the anxiolytic activity of clobazam.
    Sandler K; Brunswick D; Digiacomo J; Mendels J
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):114-6. PubMed ID: 12920
    [No Abstract]   [Full Text] [Related]  

  • 12. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
    Lipman R; Vanov SK; Richards DJ
    Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phytopharmacy-- traditional empiricism or pharmacological evidence? Part 1: Generalized anxiety and anxiolytics].
    Bastigkeit M
    Med Monatsschr Pharm; 2014 Sep; 37(9):316-22. PubMed ID: 25282745
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical methodology for testing of anxiolytic drugs.
    Bourin M
    Therapie; 2000; 55(1):147-53. PubMed ID: 10860018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepines and neurotic anxiety. Critique.
    Solomon K
    N Y State J Med; 1976 Dec; 76(13):2156-64. PubMed ID: 11427
    [No Abstract]   [Full Text] [Related]  

  • 16. Brief treatment of anxious patients with halazepam in high doses [proceedings].
    Kellner R; Bruzzese D; Winslow WW
    Psychopharmacol Bull; 1977 Apr; 13(2):21-2. PubMed ID: 16309
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled clinical and quantitative EEG studies of triflubazam (ORF 8063) in patients with anxiety syndrome.
    Itil TM; Akpinar S; Fink M; Polvan N; Huque M; Sungurbey K
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):307-15. PubMed ID: 5248
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical study of clobazam in patients with gastrointestinal disorders [proceedings].
    Laudano O
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):129S. PubMed ID: 35193
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of Cavain in patients suffering from anxiety.
    Lehmann E; Klieser E; Klimke A; Krach H; Spatz R
    Pharmacopsychiatry; 1989 Nov; 22(6):258-62. PubMed ID: 2575765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical activities of a new bezodiazepine: cloxazolam].
    Singer L; Krieger-Finance F; Danion JM
    Ann Med Psychol (Paris); 1980 Jan; 138(1):95-103. PubMed ID: 6104462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.